Brief: Cofactor Genomics To Evaluate Use Of Immunoprism Assay In Genocea's Clinical Trial Of Gen-009
04/12/2018 14:12
Dec 4 (Reuters) - Genocea Biosciences Inc GNCA.O :
* COFACTOR GENOMICS - ANNOUNCED PILOT STUDY TO EVALUATE USE
OF
CO'S IMMUNOPRISM ASSAY IN GENOCEA BIOSCIENCES' PHASE 1/2A
CLINICAL TRIAL OF GEN-009
Source text for Eikon: ID:nBw5zXzWYa
Further company coverage: GNCA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genocea Biosciences
See all newsBluebird, Chimerix, Clovis have under 6 months of cash left - Truist
Genocea Biosciences plunges as it winds down operations
Brief: Genocea Announces Wind Down Of Operations And Delisting From Nasdaq
Genocea Biosciences Inc reports results for the quarter ended in March - Earnings Summary
U.S. STOCKS ON THE MOVE-Oppenheimer Holdings, IES Holdings Inc, Avantor Inc